13G Filing: Armistice Capital and Eyegate Pharmaceuticals Inc (EYEG)

Page 6 of 10

Page 6 of 10 – SEC Filing

Item 3.
If This Statement is filed pursuant to ss.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a
(a)
[_]
Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).
(b)
[_]
Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
(c)
[_]
Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
(d)
[_]
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e)
[_]
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
[_]
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
[_]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
(h)
[_]
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i)
[_]
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
[_]
Group, in accordance with s.240.13d-1(b)(1)(ii)(J).
Item 4.
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned:
Armistice Capital, LLC – 1,614,000
Armistice Capital Master Fund Ltd. – 1,614,000
Steven Boyd – 1,614,000
(b)
Percent of class:
Armistice Capital, LLC – 9.9%
Armistice Capital Master Fund Ltd. – 9.9%
Steven Boyd – 9.9%
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote
Armistice Capital, LLC – 0
Armistice Capital Master Fund Ltd. – 0
Steven Boyd – 0
(ii)
Shared power to vote or to direct the vote
Armistice Capital, LLC – 1,614,000
Armistice Capital Master Fund Ltd. – 1,614,000
Steven Boyd – 1,614,000
(iii)
Sole power to dispose or to direct the disposition of
Armistice Capital, LLC – 0
Armistice Capital Master Fund Ltd. – 0
Steven Boyd – 0
(iv)
Shared power to dispose or to direct the disposition of
Armistice Capital, LLC – 1,614,000
Armistice Capital Master Fund Ltd. – 1,614,000
Steven Boyd –1,614,000

Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)

Page 6 of 10